愛玩股
English
基本資料
相對強度
財報分析
成長能力
財務比率
現金流量
償債能力
成本分析
實用連結
雅虎財經
公司簡介
研究報告
在外流通股數
歷史市銷率
歷史本益比
盈餘估計修正
存貨周轉率
應收帳款周轉率
內部人交易
新聞
Dermata Therapeutics, Inc. Warrant (
DRMAW
) - Nasdaq
Discover real-time Dermata Therapeutics, Inc. Warrant (
DRMAW
)
stock
prices, quotes, historical data, news, and Insights for informed trading and investment ...
drmaw
dermata therapeutics inc c/wts (to pur com) - Moomoo
US
Stock
MarketDetailed Quotes.
DRMAW
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM). Close Mar 22 16:00 ET. 0.0114. +0.0002 +1.79%. Market Cap0. P/E (TTM)0.00.
DRMAW
(Dermata Therapeutics Inc. Warrant)
Stock
Info
DRMAW
(Dermata Therapeutics Inc. Warrant) ○ Nasdaq — Market Cap: 2.8M USD.
DRMAW
is trending strongly down. More on the latest in-depth technical and ...
Dermata Therapeutics, Inc. (DRMA)
Stock
Price, Quote & News
Get a real-time Dermata Therapeutics, Inc. (DRMA)
stock
price quote with breaking news, financials, statistics, charts and more ... (Nasdaq:DRMA;
DRMAW
) ("Dermata ...
Dermata Therapeutics Inc - Warrants (13/08/2026)
Stock
...
Based on our forecasts, a long-term increase is expected, the "
DRMAW
"
stock
price prognosis for 2029-04-10 is 0.112 USD. With a 5-year investment, the revenue ...
Dermata Therapeutics Inc (DRMA) - Shares - Investing.com
View the real-time Dermata Therapeutics Inc (NASDAQ DRMA) share price and assess historical data, charts, technical analysis and the share chat forum.
Dermata Announces Exercise of Warrants for $2.26 Million in ...
(NASDAQ:DRMA)(NASDAQ:
DRMAW
) ("Dermata" or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical and ...
免責聲明
本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。